Outlook Therapeutics CEO C Trenary receives $7.5M in 2021
Outlook Therapeutics reports 2021 executive compensation
By ExecPay News
Published: January 27, 2022
Outlook Therapeutics reported fiscal year 2021 executive compensation information on January 27, 2022.
In 2021, four executives at Outlook Therapeutics received on average a compensation package of $2.7M, a 435% increase compared to previous year.
Average pay of disclosed executives at Outlook Therapeutics
C. Russell Trenary III, Chief Executive Officer, received $7.5M in total. 98% of Trenary's compensation, or $7.3M, was in option awards. Trenary also received $145K in salary and $6.2K in other compensation.
Lawrence A. Kenyon, Chief Financial Officer, received a compensation package of $2.7M, which increased by 125% compared to previous year. 75% of the compensation package, or $2M, was in option awards.
Terry Dagnon, Chief Operations Officer, earned $300K in 2021, a 88% increase compared to previous year.
Jeff Evanson, Chief Commercial Officer, received $300K in 2021, which increases by 88% compared to 2020.
Outlook Therapeutics' fiscal year ends on September 30.
Related executives
You may also like
Source: SEC filing on January 27, 2022.